Standard
Effects of albuminuria-lowering treatments on inflammation markers : A post hoc analysis from the ROTATE trials. / Sen, Taha; Curovic, Viktor Rotbain; Jongs, Niels; Laverman, Gozewijn D.; Kooy, Adriaan; Persson, Frederik; Rossing, Peter; Heerspink, Hiddo J.L.
In:
Diabetes, Obesity and Metabolism, Vol. 25, No. 8, 2023, p. 2413-2418.
Research output: Contribution to journal › Letter › Research › peer-review
Harvard
Sen, T, Curovic, VR, Jongs, N, Laverman, GD, Kooy, A, Persson, F
, Rossing, P & Heerspink, HJL 2023, '
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials',
Diabetes, Obesity and Metabolism, vol. 25, no. 8, pp. 2413-2418.
https://doi.org/10.1111/dom.15109APA
Sen, T., Curovic, V. R., Jongs, N., Laverman, G. D., Kooy, A., Persson, F.
, Rossing, P., & Heerspink, H. J. L. (2023).
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials.
Diabetes, Obesity and Metabolism,
25(8), 2413-2418.
https://doi.org/10.1111/dom.15109Vancouver
Sen T, Curovic VR, Jongs N, Laverman GD, Kooy A, Persson F et al.
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials.
Diabetes, Obesity and Metabolism. 2023;25(8):2413-2418.
https://doi.org/10.1111/dom.15109Author
Sen, Taha ; Curovic, Viktor Rotbain ; Jongs, Niels ; Laverman, Gozewijn D. ; Kooy, Adriaan ; Persson, Frederik ; Rossing, Peter ; Heerspink, Hiddo J.L. / Effects of albuminuria-lowering treatments on inflammation markers : A post hoc analysis from the ROTATE trials. In: Diabetes, Obesity and Metabolism. 2023 ; Vol. 25, No. 8. pp. 2413-2418.
Bibtex
@article{eb13a5acfd324117bf6af4c9fcf190f9,
title = "Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials",
keywords = "ARB, baricitinib, DPP-4 inhibitor, empagliflozin, inflammation, inflammatory markers, JAK–STAT inhibitor, linagliptin, SGLT2 inhibitor, telmisartan",
author = "Taha Sen and Curovic, {Viktor Rotbain} and Niels Jongs and Laverman, {Gozewijn D.} and Adriaan Kooy and Frederik Persson and Peter Rossing and Heerspink, {Hiddo J.L.}",
note = "Funding Information: TS is supported by the BEAt‐DKD project. The BEAt‐DKD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115974. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and EFPIA. ",
year = "2023",
doi = "10.1111/dom.15109",
language = "English",
volume = "25",
pages = "2413--2418",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "8",
}
RIS
TY - JOUR
T1 - Effects of albuminuria-lowering treatments on inflammation markers
T2 - A post hoc analysis from the ROTATE trials
AU - Sen, Taha
AU - Curovic, Viktor Rotbain
AU - Jongs, Niels
AU - Laverman, Gozewijn D.
AU - Kooy, Adriaan
AU - Persson, Frederik
AU - Rossing, Peter
AU - Heerspink, Hiddo J.L.
N1 - Funding Information:
TS is supported by the BEAt‐DKD project. The BEAt‐DKD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115974. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and EFPIA.
PY - 2023
Y1 - 2023
KW - ARB
KW - baricitinib
KW - DPP-4 inhibitor
KW - empagliflozin
KW - inflammation
KW - inflammatory markers
KW - JAK–STAT inhibitor
KW - linagliptin
KW - SGLT2 inhibitor
KW - telmisartan
U2 - 10.1111/dom.15109
DO - 10.1111/dom.15109
M3 - Letter
C2 - 37166080
AN - SCOPUS:85159068030
VL - 25
SP - 2413
EP - 2418
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 8
ER -
